A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2001
10/25/2001	CA2406226A1 Rapid-onset formulation of a selective cyclooxigenase-2
10/25/2001	CA2406196A1 Therapeutic uses for mesenchymal stromal cells
10/25/2001	CA2406171A1 Reversible immortalization of cells
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2404858A1 Treatment of neurodegenerative disease
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001	CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/25/2001	CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/25/2001	CA2370487A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/24/2001	EP1148059A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
10/24/2001	EP1148054A1 Thyroid receptor ligands
10/24/2001	EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001	EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001	EP1147413A2 Growth differentiation factor inhibitors and uses therefor
10/24/2001	EP1147175A2 Fibres for culturing eukaryotic cells
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001	EP1147119A1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
10/24/2001	EP1147114A1 Novel aralkyl amines of spirofuropyridines useful in therapy
10/24/2001	EP1147113A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
10/24/2001	EP1147112A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/24/2001	EP1147110A1 Pyrazino(aza)indole derivatives
10/24/2001	EP1147108A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
10/24/2001	EP1147106A1 Process for the preparation of alkyl mercapto methyl ergoline derivatives
10/24/2001	EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents
10/24/2001	EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001	EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147084A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
10/24/2001	EP1147083A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146908A1 Formulations comprising antisense nucleotides to connexins
10/24/2001	EP1146905A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain
10/24/2001	EP1146902A1 Treatment of autommune diseases by an agonistic cd40-binding protein
10/24/2001	EP1146898A1 Vaccine-mediated treatment of neurological disorders
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146885A1 Pre-conditioning against cell death
10/24/2001	EP1146871A1 Antidepressant heterocyclic compounds
10/24/2001	EP1146870A1 Antioxidant compositions and methods for companion animals
10/24/2001	EP1146868A1 Anti-inflammatory agents
10/24/2001	EP1146865A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
10/24/2001	EP1146864A1 Ph independent extended release pharmaceutical formulation
10/24/2001	EP1146862A1 Pharmaceutical compositions
10/24/2001	EP1146845A2 Compressed lecithin preparations
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	EP0892796B1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics
10/24/2001	EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001	EP0840733B1 A triazolylmethyl-indole ethylamine bisulfate salt
10/24/2001	EP0840601B1 Thip for treating sleep disorders
10/24/2001	EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them
10/24/2001	EP0705099B1 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
10/24/2001	EP0641206B1 Use of cotinine to alleviate tobacco withdrawal syndrome
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors
10/24/2001	CN1319014A Use of benzenesulfonyl (thio) ureas for treatment and prophylaxis of dysfunctions of autonomous nervous system and use of benzenesulfonyl(thio) ureas in combination with beta-receptor blockers
10/24/2001	CN1319013A Pharmaceutical agents for treatment of parkinson's diseae, ADHD and microadenomas
10/24/2001	CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors
10/24/2001	CN1319005A Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative
10/24/2001	CN1318414A Preparation of neuroregulator
10/24/2001	CN1318413A Chinese medicine for treating intractable insomnia and its preparation
10/24/2001	CN1318371A New use of flavone
10/24/2001	CN1073565C New 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, processes for their preparation
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073552C Benzamides for neurodegenerative disorder treatment
10/24/2001	CN1073440C Tea with functions of dispelling effect of alcohol, nourishing stomach and protecting liver
10/24/2001	CN1073432C Traditional chinese medicine for stopping drug-taking
10/24/2001	CN1073417C Ankang capsule for abstaining from drugs
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307027 Bradykinin B1 receptor antibodies
10/23/2001	US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis
10/23/2001	US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001	US6306910 Use of Gaba-analogues for treating insomnia
10/23/2001	US6306909 Anti-epileptogenic agents
10/23/2001	US6306907 Antipsychotic
10/23/2001	US6306903 Alpha-aminoamide derivatives useful as analgesic agents
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306878 Pharmaceutical compositions containing hydroximic acid derivatives
10/23/2001	US6306876 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
10/23/2001	US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001	US6306854 Chemical compounds

1 ... 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 ... 1833